Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesHuman genome sciences to host november 2nd conference call to discuss top-line results from second phase 3 trial of benlysta (belimumab) in systemic lupus erythematosus
Human Genome Sciences, 10/16/09
Human Genome Sciences, Inc. announced that it expects to have top–line 52–week results available on Monday, November 2nd, from BLISS–76, the second of two pivotal Phase 3 clinical trials of BENLYSTA (belimumab) in systemic lupus erythematosus (SLE).
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies
Investigational New Drugs, 12/18/09
ARIAD Announces Full Enrollment in Phase 3 Succeed Trial Evaluating Ridaforolimus in Patients with Metastatic Sarcomas
ARIAD Pharmaceuticals, 12/18/09
Milatuzumab – a promising new immunotherapeutic agent
Expert Opinion on Investigational Drugs, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor